Responding to the progress report for the clinically-led review of NHS access standards, Professor John Appleby, Chief Economist at the Nuffield Trust said:
“We agree with Professor Steve Powis that it really is too early to tell whether these new targets might be an improvement.
“From the initial analysis of A&E data, it remains unclear which people have won or lost out under this new regime. We really need to know this to decide whether longer waits for some are a price worth paying. Although new targets are likely to benefit some patients, so far many have been left to wait longer.
“Therefore it’s still uncertain whether these results truly deliver what this review was looking for – to ‘lock in short waits’. We are absolutely supportive of the idea of rigorously testing new targets, but NHS England need to make it clear what success would look like.”
Notes to editors
- You can find today’s progress report for the clinically-led review of NHS access standards on the NHS England website.
- The interim report for the clinically-led review of NHS access standards, published in March, can be found here.
- The Nuffield Trust is an independent health think tank. We aim to improve the quality of health care in the UK by providing evidence-based research and policy analysis and informing and generating debate. https://www.nuffieldtrust.org.uk